Verastem Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (22)

Latest Posts

About This Stock More About This Stock
Week In Review: Agilent Pays $250 Million To Acquire ACEA And Its Cell Therapy Analyzer
Article By: ChinaBio® Today
Saturday, September 29, 2018 4:11 PM EDT
ACEA Biosciences, a San Diego company with R&D and manufacturing facilities in Hangzhzou, will be acquired by Agilent for $250 million in cash. ACEA developed the xCELLigence® cell therapy analysis device used by academic and biopharma researchers.
In this article: A, VSTM, NVS, CBMG, TTPH
Read
3 ‘Strong Buy’ Stocks With Big Catalysts Ahead
Article By: TipRanks
Wednesday, March 14, 2018 2:21 PM EDT
Which are three of the market’s hottest stocks right now?
In this article: VSTM, AQXP, SBBP
Read
VSTM Verastem Inc – Bullish Break
Article By: Elliottwave Forecast
Wednesday, September 13, 2017 6:00 AM EDT
VSTM Verastem Inc has created a bullish break in the weekly time frame after the announcement of Positive Top-Line Data For Leukemia Treatment
In this article: VSTM
Read
Verastem Creates New 52 Weeks High
Article By: KKD Healthcare Analytics
Tuesday, March 28, 2017 1:05 PM EDT
Verastem stock has shown strong performance as it grew over 44 percent in the past 12 months.
In this article: VSTM
Read
Seven Biotech Names On The Upswing: 2016 Small-Cap Biotech Watchlist Update
Article By: The Life Sciences Report
Wednesday, March 9, 2016 5:47 PM EDT
Biotech stocks—and the stock market in general—took a dive at the beginning of 2016, headed down on macroeconomic factors such as financial instability in China.
In this article: SGYP, CRMD, ORMP, SRNE, ARRY, PTIE, AGEN, GALE, PPHM, EVOK, ADMA, AKBA, KPTI, VSTM, AST, RXDX, AGTC, WVE, FATE, FLKS, PIRS, ABEO
Read

PARTNER HEADLINES

Latest Tweets for $VSTM

No tweets yet!